Childress Capital Advisors, LLC Bristol Myers Squibb CO Transaction History
Childress Capital Advisors, LLC
- $336 Million
- Q1 2025
A detailed history of Childress Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 5,829 shares of BMY stock, worth $273,321. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,829
Previous 7,018
16.94%
Holding current value
$273,321
Previous $396,000
10.35%
% of portfolio
0.11%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.44 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.07 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.45 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...